Biote Historical Financial Ratios
| BTMD Stock | USD 3.76 0.69 22.48% |
Biote Corp is presently reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0748, Days Sales Outstanding of 11.66 or Free Cash Flow Yield of 0.2 will help investors to properly organize and evaluate biote Corp financial condition quickly.
Biote |
About Biote Financial Ratios Analysis
biote CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Biote Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Biote financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Biote Corp history.
Biote Corp Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing biote Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biote Corp sales, a figure that is much harder to manipulate than other biote Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is biote Corp dividend as a percentage of Biote Corp stock price. biote Corp dividend yield is a measure of Biote Corp stock productivity, which can be interpreted as interest rate earned on an Biote Corp investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Biote Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into biote Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.At present, Biote Corp's Free Cash Flow Yield is projected to slightly decrease based on the last few years of reporting. The current year's Operating Cash Flow Per Share is expected to grow to 2.30, whereas PTB Ratio is projected to grow to (1.97).
| 2022 | 2024 | 2025 (projected) | Dividend Yield | 0.43 | 0.0787 | 0.0748 | Price To Sales Ratio | 0.18 | 1.07 | 1.13 |
Biote Corp fundamentals Correlations
Click cells to compare fundamentals
Biote Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biote Corp fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Dividend Yield | 0.17 | 0.15 | 0.43 | 0.0685 | 0.0787 | 0.0748 | |
| Ptb Ratio | (4.46) | 17.99 | (0.68) | (4.32) | (2.07) | (1.97) | |
| Days Sales Outstanding | 14.78 | 13.7 | 15.37 | 16.1 | 14.12 | 11.66 | |
| Book Value Per Share | (2.25) | 0.54 | (7.23) | (1.42) | (2.98) | (3.13) | |
| Free Cash Flow Yield | 0.33 | 0.4 | (0.37) | 0.19 | 0.18 | 0.2 | |
| Operating Cash Flow Per Share | 3.49 | 4.45 | (1.14) | 1.05 | 1.32 | 2.3 | |
| Capex To Depreciation | 1.22 | 2.72 | 0.84 | 0.91 | 1.8 | 1.74 | |
| Pb Ratio | (4.46) | 17.99 | (0.68) | (4.32) | (2.07) | (1.97) | |
| Ev To Sales | 0.87 | 0.61 | 0.43 | 0.82 | 0.92 | 0.86 | |
| Free Cash Flow Per Share | 3.3 | 3.95 | (1.36) | 0.94 | 1.13 | 2.04 | |
| Roic | 1.21 | 0.81 | (0.47) | 4.68 | 0.0184 | 0.0175 | |
| Inventory Turnover | 10.39 | 5.08 | 4.88 | 2.76 | 3.92 | 7.0 | |
| Net Income Per Share | 3.85 | 4.31 | 0.16 | 0.13 | 0.0921 | 0.0875 | |
| Days Of Inventory On Hand | 35.13 | 71.89 | 74.79 | 132.09 | 93.21 | 58.66 | |
| Payables Turnover | 18.38 | 11.22 | 13.27 | 13.93 | 16.02 | 15.5 | |
| Capex To Revenue | 0.012 | 0.0273 | 0.0111 | 0.0146 | 0.0326 | 0.0342 | |
| Cash Per Share | 2.27 | 3.53 | 9.83 | 3.46 | 1.15 | 1.09 | |
| Pocfratio | 2.88 | 2.2 | (3.28) | 4.72 | 4.68 | 4.92 | |
| Interest Coverage | 13.11 | 20.66 | (11.93) | 4.5 | (2.87) | (2.73) | |
| Payout Ratio | 0.46 | 0.35 | 9.73 | 2.62 | 2.36 | 2.53 | |
| Capex To Operating Cash Flow | 0.0527 | 0.11 | (0.2) | 0.1 | 0.14 | 0.15 | |
| Pfcf Ratio | 3.04 | 2.48 | (2.73) | 5.25 | 5.46 | 5.73 | |
| Days Payables Outstanding | 19.86 | 32.52 | 27.5 | 26.2 | 36.5 | 22.58 | |
| Income Quality | 0.91 | 1.03 | (6.92) | 8.11 | 983.54 | 1.0K | |
| Roe | (1.71) | 7.91 | (0.0298) | (0.11) | (0.0309) | (0.0293) | |
| Ev To Operating Cash Flow | 3.83 | 2.51 | (7.78) | 5.69 | 4.03 | 2.33 | |
| Pe Ratio | 2.61 | 2.28 | 22.71 | 38.3 | 67.09 | 70.44 | |
| Return On Tangible Assets | 0.97 | 0.66 | 0.0124 | 0.0221 | 0.0284 | 0.027 | |
| Ev To Free Cash Flow | 4.05 | 2.83 | (6.48) | 6.32 | 4.69 | 2.97 | |
| Earnings Yield | 0.38 | 0.44 | 0.044 | 0.0261 | 0.0149 | 0.0142 | |
| Intangibles To Total Assets | 0.0798 | 0.0838 | 0.0454 | 0.032 | 0.0926 | 0.0751 | |
| Net Debt To E B I T D A | 0.76 | 0.29 | 4.46 | 2.8 | (0.94) | (0.89) | |
| Current Ratio | 2.38 | 2.72 | 5.39 | 5.51 | 1.32 | 2.5 | |
| Tangible Book Value Per Share | (2.6) | (0.0566) | (7.86) | (1.61) | (3.31) | (3.48) | |
| Receivables Turnover | 24.7 | 26.65 | 23.74 | 22.68 | 25.84 | 27.68 | |
| Shareholders Equity Per Share | (2.25) | 0.54 | (5.52) | (1.14) | (2.98) | (3.13) | |
| Debt To Equity | (2.48) | 9.05 | (2.71) | (3.91) | (0.0945) | (0.0993) | |
| Capex Per Share | 0.18 | 0.5 | 0.23 | 0.11 | 0.19 | 0.26 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.